Yahoo
Tokyo - Delayed Quote JPY

MEDINET Co., Ltd. (2370.T)

17.00 -1.00 (-5.56%)
At close: November 6 at 3:30:00 PM GMT+9
Chart Range Bar
Loading chart for 2370.T
  • Previous Close 18.00
  • Open 17.00
  • Bid --
  • Ask --
  • Day's Range 16.00 - 17.00
  • 52 Week Range 16.00 - 39.00
  • Volume 2,193,300
  • Avg. Volume 569,661
  • Market Cap (intraday) 4.788B
  • Beta (5Y Monthly) 0.43
  • PE Ratio (TTM) --
  • EPS (TTM) -311.95
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est --
  • Moby Rating Neutral

MEDINET Co., Ltd. operates as a contract development and manufacturing organization that provides regenerative medicine and cell therapy solutions in Japan. It operates through two segments: Cell Processing Business and Regenerative Medicine Products Business.The company's solutions include technical know-how, facilities, systems, materials, professional cell-engineers, and other requirements to conduct immuno-cell therapy.It also manufactures regenerative medical/investigational and specified cell products. In addition, the company offers value chain solutions, such as personnel training, facility and equipment design, facility operations and management, preparation of standard operating procedures, logistics network, information system, purchasing and production management, quality management system, quality control and assurance, and technology transfer and process development solutions. The company serves medical institutions, research institutions, and biopharmaceutical companies. MEDINET Co., Ltd. was incorporated in 1995 and is headquartered in Tokyo, Japan.

www.medinet-inc.co.jp

92

Full Time Employees

September 30

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

2370.T
41.38%
Nikkei 225 (^N225)
14.09%

1-Year Return

2370.T
48.48%
Nikkei 225 (^N225)
12.87%

3-Year Return

2370.T
66.00%
Nikkei 225 (^N225)
75.60%

5-Year Return

2370.T
73.02%
Nikkei 225 (^N225)
93.96%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 181M
Earnings -339M
Profit Margin -187.29%

Q3

FY24

Q1

FY25

Q3

FY25

Q1

FY26

-400M
-200M
0
200M
-240.0%
-220.0%
-200.0%
-180.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -33.09%

  • Return on Equity (ttm)

    -69.34%

  • Revenue (ttm)

    998M

  • Net Income Avi to Common (ttm)

    -3.05B

  • Diluted EPS (ttm)

    -311.95

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.2B

  • Total Debt/Equity (mrq)

    2.17%

  • Levered Free Cash Flow (ttm)

    -1.55B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: